Half of the top 20 big pharma are now part of Monocl's customer portfolio
· Monocl reaches one of its most significant milestones to date, less than three years post launch · 50% of top 20 big pharma and 50% of top 10 instrument manufacturers globally are now part of the customer portfolio Monocl, the leader in life sciences stakeholder mapping and engagement, has reached its annual target and added a range of global leading customers to its cloud-based stakeholder platform. The global customer portfolio includes companies such as Pfizer, Novartis, Bayer, AstraZeneca, Amgen, ThermoFisher Scientific, Agilent and Bio-Rad Laboratories. Björn Carlsson, CEO